Cenovus Energy Inc. (TSX:CVE)
20.47
+0.24 (1.19%)
Aug 8, 2025, 4:00 PM EDT
Verve Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 2,676 | 3,142 | 4,109 | 6,450 | 587 | -2,379 | Upgrade |
Depreciation & Amortization | 5,169 | 5,096 | 4,864 | 4,489 | 4,143 | 3,071 | Upgrade |
Loss (Gain) From Sale of Assets | -18 | -119 | 20 | -269 | -229 | -81 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | -183 | 1,942 | 450 | Upgrade |
Loss (Gain) on Equity Investments | 72 | 106 | 98 | 50 | 80 | - | Upgrade |
Stock-Based Compensation | 4 | -145 | -12 | - | - | - | Upgrade |
Other Operating Activities | -853 | -150 | -498 | 291 | 623 | -986 | Upgrade |
Change in Other Net Operating Assets | 1,142 | 1,305 | -1,193 | 575 | -1,227 | 198 | Upgrade |
Operating Cash Flow | 8,192 | 9,235 | 7,388 | 11,403 | 5,919 | 273 | Upgrade |
Operating Cash Flow Growth | -21.35% | 25.00% | -35.21% | 92.65% | 2068.13% | -91.69% | Upgrade |
Capital Expenditures | -5,217 | -5,015 | -4,298 | -3,708 | -2,563 | -859 | Upgrade |
Cash Acquisitions | -236 | -22 | -515 | -397 | 735 | - | Upgrade |
Divestitures | 34 | 46 | 12 | 1,514 | 435 | 38 | Upgrade |
Investment in Securities | -29 | -80 | -125 | -211 | 17 | -4 | Upgrade |
Other Investing Activities | -96 | -55 | -369 | 488 | 434 | -38 | Upgrade |
Investing Cash Flow | -5,544 | -5,126 | -5,295 | -2,314 | -942 | -863 | Upgrade |
Short-Term Debt Issued | - | 5 | 58 | 34 | - | 117 | Upgrade |
Long-Term Debt Issued | - | - | - | - | 1,557 | 1,326 | Upgrade |
Total Debt Issued | 299 | 5 | 58 | 34 | 1,557 | 1,443 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -77 | - | Upgrade |
Long-Term Debt Repaid | - | -299 | -1,634 | -4,451 | -3,520 | -529 | Upgrade |
Total Debt Repaid | -304 | -299 | -1,634 | -4,451 | -3,597 | -529 | Upgrade |
Net Debt Issued (Repaid) | -5 | -294 | -1,576 | -4,417 | -2,040 | 914 | Upgrade |
Issuance of Common Stock | 21 | 78 | 64 | 200 | 8 | - | Upgrade |
Repurchase of Common Stock | -1,319 | -1,488 | -1,061 | -2,530 | -265 | - | Upgrade |
Preferred Dividends Paid | -37 | -45 | -36 | -26 | -34 | - | Upgrade |
Common Dividends Paid | -1,350 | -1,506 | -990 | -901 | -176 | -77 | Upgrade |
Dividends Paid | -1,387 | -1,551 | -1,026 | -927 | -210 | -77 | Upgrade |
Other Financing Activities | 2 | - | -714 | -2 | - | - | Upgrade |
Financing Cash Flow | -3,288 | -3,505 | -4,313 | -7,676 | -2,507 | 837 | Upgrade |
Foreign Exchange Rate Adjustments | 49 | 262 | -77 | 238 | 25 | -55 | Upgrade |
Net Cash Flow | -591 | 866 | -2,297 | 1,651 | 2,495 | 192 | Upgrade |
Free Cash Flow | 2,975 | 4,220 | 3,090 | 7,695 | 3,356 | -586 | Upgrade |
Free Cash Flow Growth | -50.66% | 36.57% | -59.84% | 129.29% | - | - | Upgrade |
Free Cash Flow Margin | 5.69% | 7.78% | 5.92% | 11.50% | 7.24% | -4.33% | Upgrade |
Free Cash Flow Per Share | 1.62 | 2.27 | 1.59 | 3.84 | 1.64 | -0.48 | Upgrade |
Cash Interest Paid | 356 | 356 | 402 | 647 | 811 | 381 | Upgrade |
Cash Income Tax Paid | 868 | 868 | 2,595 | 723 | 209 | 18 | Upgrade |
Levered Free Cash Flow | 3,377 | 3,974 | 2,246 | 8,176 | 2,337 | 576.25 | Upgrade |
Unlevered Free Cash Flow | 3,634 | 4,239 | 2,560 | 8,573 | 2,792 | 875.63 | Upgrade |
Change in Net Working Capital | -1,337 | -1,046 | 1,441 | -1,853 | 1,617 | -229 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.